Predictive and Prognostic Value of p16 in Head and Neck Squamous Cell Carcinoma Patients Treated with Molecular Targeted Agents or Immune Checkpoint Inhibitors: Subgroup Analysis of the TRIUMPH Study
Patients with p16 (+) showed longer PFS and OS compared to p16 (-) patients. This suggests that p16 has prognostic and predictive values in HNSCC patients who are treated with MTAs or ICIs.
Authors
- Der Sheng Sun (ORCID: https://orcid.org/0000-0003-0677-2098)
- Jung Hye Kwon
- B. Keam
- Sang Hoon Chun (ORCID: https://orcid.org/0000-0002-5847-7317)
- Hyun Chang (ORCID: https://orcid.org/0000-0002-5203-7513)
- hyerim ha
- Joo Hang Kim
- Jang Ho Cho
- Yun-Gyoo Lee
- In Gyu Hwang
- hwan jung yun
- Sung-Bae Kim
- Sang Hee Cho
- Kyoung Eun Lee
- Hyo Jung Kim
Institutions
- Ulsan College (KR)
- Ewha Womans University (KR)
- Chungnam National University (KR)
- Kosin University Gospel Hospital (KR)
- Asan Medical Center (KR)
- Seoul National University Hospital (KR)
- University of Ulsan (KR)
- Chonnam National University Hospital (KR)
- Kangbuk Samsung Hospital (KR)
- Regional Cancer Center (US)
- Ewha Womans University Medical Center (KR)
- The Catholic University of Korea Bucheon St. Mary's Hospital (KR)
- CHA University Bundang Medical Center (KR)
- Chungnam National University Hospital (KR)
- Chonnam National University Hwasun Hospital (KR)
- Catholic Kwandong University International St. Mary's Hospital (KR)
- Inha University Hospital (KR)
- Chung-Ang University Hospital (KR)
- Hallym University Sacred Heart Hospital (KR)
- Sungkyunkwan University (KR)
- Catholic University of Korea (KR)
Publication Details
- Journal
- Cancer Investigation
- Published
- 2026-02-06
- DOI
- https://doi.org/10.1080/07357907.2026.2618577
- Primary Topic
- Head and Neck Cancer Studies
- Type
- article
- Field-Weighted Citation Impact
- 0.00